NotesProteins destined for the peroxisome matrix or membrane possess distinct targeting signals that engage signal sequence receptors to drive their transport to their final subcellular destination. Peroxisomal targeting signal 1 (PTS1) and 2 (PTS2) are well characterized as signaling the import from the cytosol into the peroxisomal matrix of soluble peroxisomal enzymes. PTS1 is a peptide with a three-amino acid sequence of serine (S), lysine (K), and leucine (L) (SKL motif) in the extreme COOH terminus of the protein. However, recent studies revealed that PTS1 has a wide range of variants with respect to the length, sequences, and position of the amino acid residues. The membrane protein is considered to be localized through a different mechanism because the SKL motif has never been found in peroxisomal membrane proteins. The soluble protein is thought to have the main signal for localization because the SKL motif exists in most soluble peroxisomal proteins. PTS1 signals bind to their receptor, Pex5p, for the protein to be targeted to peroxisome. PTS2 is located at or near the NH 2 termini of some peroxisomal matrix proteins with a wide range of consensus sequences. PTS2 interacts with their import receptor, Pex7p, and the proteins with PTS2 signals are targeted to peroxisome.Alanine : glyoxylate aminotransferase (AGT) is a liver-specific peroxisomal enzyme. Deficiency in AGT causes primary hyperoxaluria type I (PH1), which is a rare autosomal recessive disease. AGT is a protein composed of 392 amino acids (a.a.), and it has a similar lysine (K), lysine (K), and leucine (L) (KKL) amino acid sequence to that of the SKL motif in the extreme COOH terminus. It was reported that the COOH-terminal tripeptide KKL of human AGT is necessary as the peroxisomal targeting sequence. However, the peroxisomal targeting signal of AGT and the mechanism of targeting to peroxisome are still unclear. [1][2][3][4][5] In the present paper, human-origin AGT was targeted into peroxisome at specific regions of the AGT (59-66 a.a. and 389-392 a.a.) in HeLa cells using enhanced green fluorescent protein (eGFP)-tagged AGT and deletion mutants. In the three-dimensional structural model their sites were separately located on the surface of the AGT protein.
MATERIALS AND METHODS
Construction of PlasmidsThe expression vector for the eGFP-tagged full-length AGT1-392 a.a. (AGT fused to the COOH terminus of eGFP), pEGFPAGT1-392, was constructed by inserting the cDNA fragment of AGT PCR-amplified from the expression vector of the human-origin AGT, pTrcHis2AGT (a gift from Dr. S. Hirose, Fukuoka University, Fukuoka, Japan) into the EcoRI site of the multi-cloning site (MCS) of the expression vector of eGFP, pEGFP-C1 (Clontech Co., Palo Alto, CA, U.S.A.). The expression vectors of the eGFP-tagged AGT deletion mutants were constructed by modifying pEGFPAGT1-392. The full-length AGT and deletion mutants used in the paper are schematically shown in Fig. 1.Cell Culture and Transfection HeLa cells and COS-7 cells were purchased from the Institute of Phy...